Cited by 26HIV Research and TreatmentVirus-based gene therapy researchHIV/AIDS drug development and treatment

Cellular specificity of HIV-1 replication can be controlled by LTR sequences

Open access
Reed-Inderbitzin, Edward, Maury, Wendy·2003·Virology

Abstract

Two well-established determinants of retroviral tropism are envelope sequences that regulate entry and LTR sequences that can regulate viral expression in a cell-specific manner. Studies with human immunodeficiency virus-1 (HIV-1) have demonstrated that tropism of this virus maps primarily to variable envelope sequences. Studies have demonstrated that T cell and macrophage-specific transcription factor binding motifs exist in the upstream region of the LTR U3; however, the ability of the core enhancer/promoter proximal elements (two NF-kappaB and three Sp1 sites) to function well in macrophages and T cells have led many to conclude that HIV LTR sequences are not primary determinants of HIV tropism. To determine if cellular specificity could be imparted to HIV by the core enhancer elements, the enhancer/promoter proximal region of the HIV LTR was substituted with motifs that control gene expression in a myeloid-specific manner. The enhancer region from equine infectious anemia virus (EIAV) when substituted for the HIV enhancer/promoter proximal region was found to drive expression in a macrophage-specific manner and was responsive to HIV Tat. The addition of a 5' methylation-dependent binding site (MDBP) and a promoter proximal Sp1 motif increased expression without altering cellular specificity. Spacing between the promoter proximal region and the TATA box was also found to influence LTR activity. Infectivity studies using chimeric LTRs within the context of a dual-tropic infectious molecular clone established that these LTRs directed HIV replication and production of infectious virions in macrophages but not primary T cells or T cell lines. This investigation demonstrates that cellular specificity can be imparted onto HIV-1 replication at the level of viral transcription and not entry.

Integrity signals

Registry

Crossref · 10.1016/s0042-6822(03)00508-7

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The specific characteristics of enhancer sequences play a crucial role in determining the tissue specificity of viral replication and consequently the pathogenesis of the virus.

    “The specific characteristics of the enhancer sequences play a crucial role in determining the tissue specificity of viral replication and, consequently, the pathogenesis of the virus (Coffin 1997, Reed-Inderbitzin and Maury 2003, Hunter 2008).”

    From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Reed-Inderbitzin and Maury 2003

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Reed-Inderbitzin, E., & Maury, W.
Affiliations
  • University of South Dakota (US)
  • University of Iowa (US)
Corresponding author
Maury, Wendy
Venue
Virology
Publisher
Elsevier BV
Published
2003-09
Volume
314
Issue
2
Pages
680-695
ISSN
0042-6822 (ISSN-L)
OpenAlex
W1967893165
Cited by
26
References
4
Citations by year
2025: 3 · 2022: 1 · 2015: 2 · 2014: 1 · 2013: 1
FWCI
0.81
Type
journal article
Language
en
Open access
Locations
  • Virology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1r15ai039704-01)
  • National Institute of Allergy and Infectious Diseases (R15-AI39704)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
HIV-1, long terminal repeat, cell tropism, Tat, viral transcription
MeSH terms
Base Sequence, Cell Line, Humans, Macrophages, Species Specificity, Virus Replication, CD4-Positive T-Lymphocytes, HIV-1, Gene Expression Regulation, Viral, HIV Enhancer, HIV Long Terminal Repeat, Jurkat Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review